kr 19.54 ($1.94)

-0.14 (-0.71%)

Weekly Expected Move ±4.8%

kr 18 kr 19 kr 20 kr 20 kr 21

STO · Healthcare · Biotechnology · Tech Score Neutral · Power 49 · kr 1.3B mcap · 57M float · 0.189% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-

Oct 02, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. GENO.ST receives an overall rating of B-. Strongest factors: ROA (5/5). Areas of concern: D/E (1/5), P/E (1/5), P/B (2/5).

Rating Change History

Date	From	To
2026-10-01	B	B-
2026-09-24	B-	B
2026-07-24	B	B-
2026-07-23	B-	B
2026-07-20	B	B-
2026-07-08	B-	B
2026-07-01	B	B-
2026-05-05	B-	B
2026-04-07	None	ADDED
2026-04-07	EXISTED	None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 53 Grade B

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

100

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. GENO.ST scores highest in Safety (100/100) and lowest in Growth (31/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

7.51

Safe Zone

Piotroski F-Score

4/9

✓ ✓ ✗ ✓ ✓ ✗ ✗ ✗ ✗

Beneish M-Score

-1.78

Possible Manipulator

Ohlson O-Score

-9.09

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

AA+

Score: 94.6/100

Trend: Stable

Earnings Quality

75/100

OCF/NI: 2.50x

Accruals: -8.1%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. GENO.ST scores 7.51, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. GENO.ST scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. GENO.ST's score of -1.78 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. GENO.ST's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. GENO.ST receives an estimated rating of AA+ (score: 94.6/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). GENO.ST's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

65.13x

PEG

-2.43x

P/S

9.52x

P/B

4.22x

P/FCF

40.68x

P/OCF

25.60x

EV/EBITDA

35.31x

EV/Revenue

9.11x

EV/EBIT

61.63x

EV/FCF

38.33x

Earnings Yield

1.56%

FCF Yield

2.46%

Shareholder Yield

0.00%

Graham Number

$5.67

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 65.1x earnings, GENO.ST is priced for high growth expectations. Graham's intrinsic value formula yields $5.67 per share, 245% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.819

NI / EBT

Interest Burden

1.249

EBT / EBIT

EBIT Margin

0.148

EBIT / Rev

Asset Turnover

0.356

Rev / Assets

Equity Multiplier

1.393

Assets / Equity

ROE

7.5%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. GENO.ST's ROE of 7.5% is driven by Asset Turnover (0.356), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

$2.62

Price/Value

7.52x

Margin of Safety

-652.23%

Premium

652.23%

Assessment

Overvalued

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with GENO.ST's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. GENO.ST trades at a 652% premium to its adjusted intrinsic value of $2.62, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 65.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$19.54

Median 1Y

$16.11

5th Pctile

$6.10

95th Pctile

$42.74

Ann. Volatility

60.8%

25th–75th percentile 5th–95th percentile Median path Historical

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	13.2%	24.7%	33.8%	33.1%	36.6%	9.3%	28.6%	36.2%	33.6%	38.9%	16.4%	8.7%	13.5%	15.7%	10.8%	12.1%	8.7%	9.4%	9.5%	7.5%	7.50%
ROA	11.1%	20.0%	28.6%	28.2%	31.0%	7.7%	24.7%	31.6%	24.2%	28.0%	12.3%	6.7%	9.1%	10.7%	7.5%	8.5%	6.2%	6.7%	6.8%	5.4%	5.38%
ROIC	23.1%	69.6%	66.1%	64.0%	66.2%	31.9%	78.5%	79.8%	39.4%	42.8%	21.0%	11.9%	19.7%	23.4%	17.7%	17.7%	5.9%	7.5%	10.3%	7.1%	7.06%
ROCE	7.7%	23.0%	27.1%	26.0%	27.7%	6.2%	23.5%	24.4%	17.2%	21.3%	10.5%	9.2%	14.7%	15.3%	11.9%	11.7%	5.3%	6.0%	5.8%	5.1%	5.11%
Gross Margin	80.5%	90.9%	86.6%	88.7%	83.3%	80.8%	92.7%	89.4%	86.2%	8.0%	36.4%	8.5%	87.9%	88.1%	89.8%	90.8%	90.3%	88.9%	88.5%	90.2%	90.15%
Operating Margin	4.2%	57.3%	29.8%	0.9%	18.5%	-9.7%	60.0%	19.0%	14.9%	8.0%	36.4%	8.5%	67.0%	19.1%	19.8%	12.0%	12.3%	20.0%	17.2%	8.2%	8.23%
Net Margin	4.8%	58.1%	36.3%	2.7%	21.2%	-45.6%	60.2%	48.4%	10.4%	-1.5%	31.8%	6.1%	41.9%	16.4%	10.7%	17.7%	29.2%	17.1%	12.7%	3.8%	3.83%
EBITDA Margin	12.5%	67.7%	34.5%	8.4%	25.9%	-2.9%	62.3%	24.4%	25.0%	23.8%	43.2%	17.8%	74.7%	27.8%	26.9%	20.9%	25.0%	29.2%	28.4%	19.9%	19.94%
FCF Margin	10.9%	46.9%	35.3%	36.2%	35.4%	-3.8%	30.4%	28.1%	27.9%	35.5%	23.4%	24.6%	20.5%	28.2%	24.2%	24.6%	25.1%	20.6%	24.7%	23.8%	23.75%
OCF Margin	13.0%	48.8%	36.2%	36.7%	36.0%	-0.9%	33.4%	33.1%	35.5%	42.0%	30.6%	29.3%	21.9%	28.5%	24.2%	20.1%	29.8%	24.8%	29.1%	37.7%	37.75%
ROE 3Y Avg	snapshot only																				8.75%
ROE 5Y Avg	snapshot only																				16.99%
ROA 3Y Avg	snapshot only																				6.18%
ROIC 3Y Avg	snapshot only																				15.43%
ROIC Economic	snapshot only																				4.24%
Cash ROA	snapshot only																				11.96%
Cash ROIC	snapshot only																				22.04%
CROIC	snapshot only																				13.87%
NOPAT Margin	snapshot only																				12.10%
Pretax Margin	snapshot only																				18.46%
R&D / Revenue	snapshot only																				0.00%
SGA / Revenue	snapshot only																				0.00%
SBC / Revenue	snapshot only																				0.00%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	335.67	192.33	96.87	78.18	53.70	268.86	102.28	54.17	55.83	55.35	71.28	107.98	63.80	49.12	52.03	64.35	72.50	59.74	49.10	63.94	65.133
P/S Ratio	51.44	51.38	31.77	24.55	17.70	29.38	30.83	20.96	20.19	21.10	16.95	14.66	13.73	12.40	10.03	14.22	13.17	10.89	9.17	9.66	9.519
P/B Ratio	41.81	41.92	27.77	22.04	16.54	23.94	25.53	16.52	15.91	17.84	10.66	8.97	8.01	7.09	5.29	7.26	5.83	5.17	4.30	4.25	4.220
P/FCF	471.58	109.65	90.11	67.85	49.92	-779.04	101.30	74.69	72.38	59.40	72.54	59.54	66.87	43.96	41.43	57.88	52.51	52.88	37.04	40.68	40.685
P/OCF	396.55	105.38	87.74	66.87	49.16	—	92.25	63.28	56.94	50.25	55.38	49.97	62.73	43.57	41.43	70.60	44.23	43.84	31.50	25.60	25.602
EV/EBITDA	285.61	143.30	81.22	65.60	45.54	144.61	78.77	50.22	50.10	50.27	54.50	49.26	31.72	27.76	24.40	35.00	52.40	41.40	32.23	35.31	35.310
EV/Revenue	50.88	50.53	31.13	23.93	17.13	28.74	30.06	20.22	19.93	20.83	16.50	14.20	13.12	11.69	9.21	13.50	13.20	10.71	8.46	9.11	9.106
EV/EBIT	517.79	173.89	94.49	77.47	53.54	355.56	101.79	62.92	64.05	58.83	72.03	69.17	38.98	33.33	31.31	44.50	83.95	65.51	53.26	61.63	61.627
EV/FCF	466.45	107.85	88.28	66.13	48.32	-762.08	98.76	72.06	71.47	58.63	70.61	57.67	63.89	41.43	38.06	54.96	52.64	52.00	34.18	38.33	38.334
Earnings Yield	0.3%	0.5%	1.0%	1.3%	1.9%	0.4%	1.0%	1.8%	1.8%	1.8%	1.4%	0.9%	1.6%	2.0%	1.9%	1.6%	1.4%	1.7%	2.0%	1.6%	1.56%
FCF Yield	0.2%	0.9%	1.1%	1.5%	2.0%	-0.1%	1.0%	1.3%	1.4%	1.7%	1.4%	1.7%	1.5%	2.3%	2.4%	1.7%	1.9%	1.9%	2.7%	2.5%	2.46%
Price/Tangible Book	snapshot only																				7.475
EV/OCF	snapshot only																				24.122
EV/Gross Profit	snapshot only																				10.183
Acquirers Multiple	snapshot only																				61.627
Shareholder Yield	snapshot only																				0.00%
Graham Number	snapshot only																				$5.67

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	5.95	4.49	8.95	8.31	7.96	5.94	7.77	8.99	8.05	7.49	8.47	9.59	8.97	7.38	8.27	12.69	10.78	7.36	7.65	5.76	5.756
Quick Ratio	5.95	3.98	8.95	8.31	7.96	5.24	7.77	8.99	8.05	6.79	8.47	9.59	8.97	6.91	8.27	12.69	10.78	7.36	7.65	5.76	5.756
Debt/Equity	0.04	0.02	0.05	0.05	0.08	0.06	0.04	0.03	0.42	0.42	0.38	0.37	0.34	0.34	0.32	0.34	0.60	0.52	0.28	0.26	0.264
Net Debt/Equity	-0.45	-0.69	-0.56	-0.56	-0.53	-0.52	-0.64	-0.58	-0.20	-0.23	-0.28	-0.28	-0.36	-0.41	-0.43	-0.37	0.01	-0.09	-0.33	-0.25	-0.246
Debt/Assets	0.04	0.02	0.04	0.04	0.06	0.05	0.03	0.03	0.28	0.27	0.26	0.26	0.24	0.23	0.23	0.24	0.43	0.37	0.21	0.19	0.190
Debt/EBITDA	0.30	0.09	0.15	0.14	0.22	0.36	0.12	0.10	1.35	1.19	2.01	2.12	1.42	1.40	1.63	1.73	5.40	4.19	2.30	2.33	2.329
Net Debt/EBITDA	-3.14	-2.39	-1.68	-1.70	-1.52	-3.22	-2.03	-1.83	-0.64	-0.66	-1.49	-1.59	-1.48	-1.69	-2.16	-1.86	0.13	-0.70	-2.70	-2.17	-2.166
Interest Coverage	24.47	211.18	198.83	279.18	312.61	1.44	7.31	8.34	7.95	164.12	84.91	74.96	338.38	—	313.76	129.00	28.44	32.67	24.87	30.40	30.404
Equity Multiplier	1.17	1.24	1.16	1.17	1.18	1.20	1.16	1.13	1.53	1.51	1.48	1.46	1.44	1.44	1.42	1.40	1.39	1.39	1.38	1.39	1.389
Cash Ratio	snapshot only																				4.439
Debt Service Coverage	snapshot only																				53.064
Cash to Debt	snapshot only																				1.930
FCF to Debt	snapshot only																				0.395
Defensive Interval	snapshot only																				566.8 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.72	0.75	0.87	0.90	0.94	0.70	0.82	0.82	0.67	0.73	0.52	0.49	0.42	0.42	0.39	0.38	0.34	0.37	0.37	0.36	0.356
Inventory Turnover	—	0.93	—	—	—	1.20	—	—	—	2.76	—	—	—	4.22	—	—	—	1.95	—	—	—
Receivables Turnover	—	8.01	—	—	—	7.64	—	—	—	10.74	—	—	—	7.98	—	—	—	14.80	—	—	—
Payables Turnover	2.00	5.86	—	1.25	1.47	3.76	—	1.12	1.04	7.76	—	5.03	4.09	15.57	3.44	0.88	1.15	7.76	0.65	0.70	0.704
DSO	0	46	0	0	0	48	0	0	0	34	0	0	0	46	0	0	0	25	0	0	0.0 days
DIO	0	394	0	0	0	304	0	0	0	132	0	0	0	87	0	0	0	187	0	0	0.0 days
DPO	183	62	0	291	249	97	0	327	352	47	0	73	89	23	106	413	319	47	559	519	518.7 days
Cash Conversion Cycle	-183	377	0	-291	-249	254	0	-327	-352	119	0	-73	-89	109	-106	-413	-319	165	-559	-519	-518.7 days
Fixed Asset Turnover	snapshot only																				1.676
Cash Velocity	snapshot only																				0.863
Capital Intensity	snapshot only																				3.155

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	37.6%	53.8%	71.1%	62.5%	68.2%	10.1%	26.8%	28.3%	21.2%	57.5%	-8.4%	-13.7%	-13.8%	-19.2%	-5.0%	-4.0%	-10.1%	-1.1%	6.2%	11.2%	11.16%
Net Income	4.9%	2.9%	3.0%	2.1%	2.6%	-55.0%	16.5%	58.1%	33.0%	4.5%	-27.7%	-69.7%	-48.7%	-46.5%	-23.0%	56.3%	-24.1%	-28.6%	2.8%	-24.0%	-23.97%
EPS	4.9%	2.9%	3.0%	2.1%	2.6%	-55.0%	16.5%	58.1%	33.0%	4.5%	-27.7%	-69.7%	-48.7%	-46.5%	-23.0%	56.3%	-24.8%	-29.3%	1.9%	-25.2%	-25.18%
FCF	5.9%	16.0%	4.5%	6.7%	4.5%	-1.1%	9.4%	-0.5%	-4.6%	15.8%	-29.7%	-24.3%	-36.5%	-35.8%	-1.5%	-4.2%	9.8%	-27.8%	8.5%	7.5%	7.47%
EBITDA	3.6%	2.8%	2.7%	1.9%	2.5%	-38.0%	26.2%	41.6%	28.3%	2.3%	-27.3%	-38.2%	-10.4%	-17.9%	18.5%	28.5%	-45.2%	-39.3%	-26.2%	-25.7%	-25.71%
Op. Income	4.7%	6.8%	5.1%	3.0%	4.1%	-44.1%	37.9%	60.1%	40.5%	3.1%	-42.1%	-55.0%	-20.9%	-20.7%	33.3%	56.7%	-55.1%	-52.1%	-43.0%	-46.2%	-46.18%
OCF Growth	snapshot only																				1.08%
Asset Growth	snapshot only																				28.07%
Equity Growth	snapshot only																				28.97%
Debt Growth	snapshot only																				-0.15%
Shares Change	snapshot only																				1.61%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	33.2%	38.9%	39.8%	38.2%	28.2%	19.1%	33.0%	32.2%	41.0%	38.7%	25.7%	21.6%	20.7%	11.9%	3.3%	2.0%	-2.1%	8.0%	-2.6%	-2.7%	-2.71%
Revenue 5Y	34.5%	38.1%	50.8%	49.3%	50.8%	35.0%	42.0%	40.1%	37.0%	36.0%	26.0%	23.9%	17.1%	16.6%	15.4%	13.9%	16.8%	16.3%	14.9%	13.9%	13.93%
EPS 3Y	—	—	2.0%	96.2%	50.7%	4.1%	92.2%	1.6%	—	1.1%	49.4%	13.6%	35.1%	9.8%	-13.4%	-9.2%	-19.9%	27.7%	-17.2%	-29.3%	-29.26%
EPS 5Y	—	—	—	—	—	—	—	—	—	—	86.1%	29.3%	18.5%	27.1%	31.6%	54.1%	—	29.3%	21.2%	11.4%	11.39%
Net Income 3Y	—	—	2.0%	98.7%	52.6%	5.4%	92.2%	1.6%	—	1.1%	49.4%	13.6%	35.1%	9.8%	-13.4%	-9.2%	-19.7%	28.1%	-17.0%	-28.9%	-28.88%
Net Income 5Y	—	—	—	—	—	—	—	—	—	—	87.5%	30.3%	19.4%	28.1%	31.6%	54.1%	—	29.5%	21.5%	11.8%	11.75%
EBITDA 3Y	1.9%	1.2%	98.1%	70.5%	47.0%	15.3%	75.0%	98.4%	1.8%	98.3%	50.8%	37.1%	59.8%	18.7%	2.8%	4.0%	-14.3%	17.9%	-14.0%	-16.1%	-16.14%
EBITDA 5Y	—	—	—	—	—	—	—	—	1.5%	85.4%	48.2%	34.1%	29.6%	32.8%	35.8%	44.0%	59.2%	31.2%	24.6%	19.7%	19.73%
Gross Profit 3Y	29.2%	33.9%	35.3%	32.6%	25.5%	15.9%	31.2%	32.4%	38.1%	29.3%	4.8%	-11.7%	-9.3%	-4.6%	-3.9%	2.7%	-1.3%	9.9%	-2.3%	-2.6%	-2.55%
Gross Profit 5Y	33.7%	36.0%	49.4%	46.9%	49.4%	32.0%	39.1%	38.3%	35.1%	29.5%	12.9%	1.0%	-2.6%	4.7%	8.9%	14.0%	15.4%	15.2%	13.6%	13.0%	12.99%
Op. Income 3Y	—	—	1.4%	77.4%	43.8%	10.9%	96.1%	1.5%	—	1.6%	69.6%	42.4%	78.6%	21.9%	2.1%	4.1%	-20.7%	15.8%	-24.0%	-27.6%	-27.59%
Op. Income 5Y	—	—	—	—	—	—	—	—	—	—	63.2%	32.1%	27.0%	34.6%	42.2%	62.2%	—	46.6%	29.9%	19.5%	19.50%
FCF 3Y	—	—	1.7%	2.9%	83.0%	—	1.1%	92.0%	—	1.8%	61.9%	79.4%	49.0%	-5.5%	-8.8%	-10.3%	-12.7%	—	-9.1%	-8.0%	-7.97%
FCF 5Y	—	—	—	—	—	—	—	—	—	—	71.4%	1.1%	30.0%	32.7%	43.2%	38.7%	—	59.7%	35.3%	42.8%	42.84%
OCF 3Y	—	—	1.3%	1.3%	64.3%	—	74.1%	78.0%	2.3%	1.6%	64.1%	72.2%	43.7%	-6.5%	-9.6%	-16.5%	-8.1%	—	-7.0%	1.6%	1.62%
OCF 5Y	—	—	—	—	—	—	—	—	—	—	62.5%	60.1%	23.0%	23.1%	27.2%	23.2%	89.2%	52.3%	33.5%	47.6%	47.61%
Assets 3Y	39.5%	55.3%	54.9%	51.7%	42.3%	45.3%	27.2%	28.8%	44.0%	39.4%	41.1%	41.7%	44.3%	32.2%	30.9%	30.8%	32.5%	35.9%	24.8%	26.6%	26.55%
Assets 5Y	35.7%	45.3%	50.3%	41.5%	44.5%	41.7%	45.1%	37.6%	49.5%	50.2%	50.3%	48.0%	42.4%	46.2%	28.2%	27.6%	30.1%	28.8%	28.8%	32.0%	32.02%
Equity 3Y	54.2%	63.5%	66.2%	63.9%	53.8%	52.2%	26.8%	32.6%	33.2%	29.8%	32.2%	32.2%	34.7%	26.0%	22.3%	23.1%	25.7%	29.3%	17.7%	18.1%	18.13%
Book Value 3Y	52.3%	61.5%	64.2%	61.9%	51.9%	50.4%	26.8%	32.6%	33.2%	29.8%	32.2%	32.2%	34.7%	26.0%	22.3%	23.1%	25.3%	28.9%	17.4%	17.5%	17.50%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.91	0.92	0.91	0.93	0.87	0.96	0.93	0.94	0.92	0.91	0.88	0.85	0.79	0.76	0.66	0.57	0.47	0.58	0.51	0.46	0.464
Earnings Stability	0.68	0.92	0.88	0.83	0.68	0.66	0.90	0.87	0.78	0.64	0.74	0.40	0.51	0.47	0.33	0.19	0.23	0.19	0.01	0.01	0.006
Margin Stability	0.96	0.96	0.96	0.95	0.96	0.95	0.95	0.96	0.95	0.91	0.80	0.68	0.70	0.81	0.80	0.70	0.70	0.80	0.79	0.69	0.692
Rev. Growth Consistency	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.500
Earn. Growth Consistency	0.50	0.50	1.00	1.00	1.00	0.00	1.00	1.00	1.00	0.50	0.00	0.00	0.00	0.00	0.00	0.50	0.00	0.00	0.50	0.00	0.000
FCF Positive Streak	0	1	1	1	1	0	1	1	1	0	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.20	0.50	0.50	0.50	0.50	0.50	0.93	0.50	0.87	0.50	0.89	0.50	0.81	0.81	0.91	0.50	0.90	0.89	0.99	0.90	0.904
Earnings Smoothness	—	0.00	0.00	0.00	0.00	0.24	0.85	0.55	0.72	0.00	0.68	0.00	0.36	0.39	0.74	0.56	0.73	0.67	0.97	0.73	0.728
ROE Trend	-0.02	0.05	0.20	0.20	0.26	-0.06	0.05	0.10	0.07	0.17	-0.12	-0.21	-0.17	-0.06	-0.10	-0.08	-0.12	-0.15	-0.04	-0.03	-0.031
Gross Margin Trend	-0.07	-0.06	-0.08	-0.03	-0.04	-0.06	-0.02	-0.01	0.02	-0.10	-0.33	-0.53	-0.51	-0.27	-0.03	0.27	0.26	0.24	0.27	0.27	0.270
FCF Margin Trend	0.06	0.37	0.26	0.28	0.32	-0.29	0.07	0.06	0.05	0.14	-0.09	-0.07	-0.11	0.12	-0.03	-0.02	0.01	-0.11	0.01	-0.01	-0.008
Sustainable Growth Rate	13.2%	24.7%	33.8%	33.1%	36.6%	9.3%	28.6%	36.2%	33.6%	38.9%	16.4%	8.7%	13.5%	15.7%	10.8%	12.1%	8.7%	9.4%	9.5%	7.5%	7.50%
Internal Growth Rate	12.4%	25.0%	40.0%	39.2%	45.0%	8.3%	32.8%	46.2%	31.9%	38.9%	14.0%	7.2%	10.0%	12.0%	8.1%	9.2%	6.6%	7.1%	7.3%	5.7%	5.69%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	0.85	1.83	1.10	1.17	1.09	-0.08	1.11	0.86	0.98	1.10	1.29	2.16	1.02	1.13	1.26	0.91	1.64	1.36	1.56	2.50	2.497
FCF/OCF	0.84	0.96	0.97	0.99	0.98	4.16	0.91	0.85	0.79	0.85	0.76	0.84	0.94	0.99	1.00	1.22	0.84	0.83	0.85	0.63	0.629
FCF/Net Income	snapshot only																				1.572
OCF/EBITDA	snapshot only																				1.464
CapEx/Revenue	2.1%	1.9%	1.0%	0.5%	0.6%	2.9%	3.0%	5.1%	7.6%	6.5%	7.2%	4.7%	1.4%	0.3%	0.0%	4.4%	4.7%	16.6%	16.6%	25.7%	25.72%
CapEx/Depreciation	snapshot only																				2.335
Accruals Ratio	0.02	-0.17	-0.03	-0.05	-0.03	0.08	-0.03	0.05	0.00	-0.03	-0.04	-0.08	-0.00	-0.01	-0.02	0.01	-0.04	-0.02	-0.04	-0.08	-0.081
Sloan Accruals	snapshot only																				-0.107
Cash Flow Adequacy	snapshot only																				1.468
Earnings Quality Score	snapshot only																				0.750

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Net Buyback Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Shareholder Return	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	1.58	1.01	1.07	1.10	1.10	1.40	1.02	1.18	1.15	1.12	1.13	0.74	0.68	0.71	0.65	0.72	0.86	0.88	0.93	0.82	0.819
Interest Burden (EBT/EBIT)	0.99	0.91	0.93	0.93	0.93	0.97	1.00	1.02	1.01	0.96	0.92	0.89	0.94	1.01	1.01	1.01	1.35	1.27	1.27	1.25	1.249
EBIT Margin	0.10	0.29	0.33	0.31	0.32	0.08	0.30	0.32	0.31	0.35	0.23	0.21	0.34	0.35	0.29	0.30	0.16	0.16	0.16	0.15	0.148
Asset Turnover	0.72	0.75	0.87	0.90	0.94	0.70	0.82	0.82	0.67	0.73	0.52	0.49	0.42	0.42	0.39	0.38	0.34	0.37	0.37	0.36	0.356
Equity Multiplier	1.19	1.23	1.18	1.18	1.18	1.22	1.16	1.15	1.39	1.39	1.33	1.30	1.48	1.47	1.45	1.43	1.41	1.41	1.40	1.39	1.393

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$0.17	$0.38	$0.56	$0.55	$0.62	$0.17	$0.65	$0.87	$0.83	$0.94	$0.47	$0.26	$0.43	$0.50	$0.36	$0.41	$0.32	$0.36	$0.37	$0.31	$0.31
Book Value/Share	$1.39	$1.74	$1.94	$1.95	$2.03	$1.92	$2.60	$2.85	$2.92	$2.91	$3.13	$3.17	$3.39	$3.48	$3.55	$3.65	$3.99	$4.11	$4.20	$4.63	$4.63
Tangible Book/Share	$1.14	$1.49	$1.69	$1.68	$1.74	$1.65	$2.33	$2.58	$2.64	$2.65	$2.85	$2.87	$3.27	$3.36	$3.42	$3.38	$2.77	$2.91	$3.01	$2.64	$2.64
Revenue/Share	$1.13	$1.42	$1.70	$1.75	$1.90	$1.56	$2.15	$2.25	$2.30	$2.46	$1.97	$1.94	$1.98	$1.99	$1.87	$1.86	$1.77	$1.95	$1.97	$2.04	$2.04
FCF/Share	$0.12	$0.67	$0.60	$0.63	$0.67	$-0.06	$0.65	$0.63	$0.64	$0.88	$0.46	$0.48	$0.41	$0.56	$0.45	$0.46	$0.44	$0.40	$0.49	$0.48	$0.65
OCF/Share	$0.15	$0.69	$0.61	$0.64	$0.68	$-0.01	$0.72	$0.75	$0.81	$1.03	$0.60	$0.57	$0.43	$0.57	$0.45	$0.38	$0.53	$0.48	$0.57	$0.77	$0.77
Cash/Share	$0.69	$1.24	$1.19	$1.18	$1.24	$1.11	$1.76	$1.74	$1.82	$1.88	$2.09	$2.07	$2.38	$2.59	$2.68	$2.58	$2.34	$2.47	$2.59	$2.36	$2.36
EBITDA/Share	$0.20	$0.50	$0.65	$0.64	$0.71	$0.31	$0.82	$0.91	$0.91	$1.02	$0.60	$0.56	$0.82	$0.84	$0.71	$0.72	$0.44	$0.50	$0.52	$0.53	$0.53
Debt/Share	$0.06	$0.04	$0.10	$0.09	$0.16	$0.11	$0.10	$0.09	$1.23	$1.21	$1.20	$1.18	$1.16	$1.17	$1.15	$1.25	$2.40	$2.12	$1.19	$1.22	$1.22
Net Debt/Share	$-0.63	$-1.20	$-1.09	$-1.09	$-1.08	$-1.00	$-1.66	$-1.66	$-0.59	$-0.67	$-0.89	$-0.89	$-1.21	$-1.42	$-1.53	$-1.34	$0.06	$-0.35	$-1.40	$-1.14	$-1.14

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	7.505
Altman Z-Prime	snapshot only																				14.379
Piotroski F-Score	6	7	7	9	8	4	7	8	5	7	5	5	7	6	6	7	5	4	4	4	4
Beneish M-Score	-1.94	-2.57	-1.46	-2.52	-2.29	-1.64	-1.69	-2.22	-2.37	2.46	-2.28	2.13	-2.46	-2.71	-3.13	-2.71	-1.98	-2.29	-1.70	-1.78	-1.778
Ohlson O-Score	snapshot only																				-9.094
ROIC (Greenblatt)	snapshot only																				8.04%
Net-Net WC	snapshot only																				$1.26
EVA	snapshot only																				$-6819618.11

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				AA+
Credit Score	96.98	96.90	96.89	97.15	97.14	72.66	91.79	91.85	89.65	94.57	93.17	93.25	94.76	92.13	95.07	95.03	85.50	86.61	92.90	94.59	94.592
Credit Grade	snapshot only																				2
Credit Trend	snapshot only																				-0.439
Implied Spread (bps)	snapshot only																				65.000
Industry Credit Rank	snapshot only																				94
Sector Credit Rank	snapshot only																				90

GENO.ST STO

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Sign in to InsiderStreet